The course of patients after variceal hemorrhage.

PubWeight™: 3.33‹?› | Rank: Top 1%

🔗 View Article (PMID 6970703)

Published in Gastroenterology on April 01, 1981


D Y Graham, J L Smith

Articles citing this

(truncated to the top 100)

Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut (2003) 4.47

UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut (2000) 2.33

Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization. Dig Dis Sci (2006) 1.50

Non-variceal gastrointestinal bleeding in patients with liver cirrhosis: a review. Dig Dis Sci (2012) 1.42

Management of bleeding esophageal varices. West J Med (1982) 1.40

NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci U S A (2001) 1.31

UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut (2015) 1.20

Why portal hypertensive varices bleed and bleed: a hypothesis. Gut (1995) 1.10

Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut (2001) 1.09

Right liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertension. World J Gastroenterol (2007) 1.07

Modern management of oesophageal varices. Postgrad Med J (2001) 1.03

Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis. World J Gastroenterol (2016) 1.02

Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection? Gut (2005) 0.99

Combination endoscopic band ligation and sclerotherapy compared with endoscopic band ligation alone for the secondary prophylaxis of esophageal variceal hemorrhage: a meta-analysis. Dig Dis Sci (2005) 0.99

Management of varices in patients with cirrhosis. Nat Rev Gastroenterol Hepatol (2013) 0.99

Endoscopic sclerotherapy compared with no specific treatment for the primary prevention of bleeding from esophageal varices. A randomized controlled multicentre trial [ISRCTN03215899]. BMC Gastroenterol (2003) 0.98

Independent factors associated with recurrent bleeding in cirrhotic patients with esophageal variceal hemorrhage. Dig Dis Sci (2008) 0.95

Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. First stage of a randomized, controlled trial. Ann Surg (1990) 0.94

Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal hemorrhage: a prospective randomized study. J Korean Med Sci (2006) 0.94

Endoscopic hemostasis for bleeding gastric varices treated by combination of variceal ligation and sclerotherapy with N-butyl-2-cyanoacrylate. J Gastroenterol (2007) 0.93

Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: a multivariate analysis. World J Surg (2009) 0.93

Risk of aspiration pneumonia in suspected variceal hemorrhage: the value of prophylactic endotracheal intubation prior to endoscopy. Dig Dis Sci (2007) 0.92

Predictors of a variceal source among patients presenting with upper gastrointestinal bleeding. Can J Gastroenterol (2012) 0.92

Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients. Gut (1996) 0.91

An assessment of endoscopic and concomitant management of acute variceal bleeding at a tertiary care centre. Can J Gastroenterol (2007) 0.91

The first Egyptian experience using new self-expandable metal stents in acute esophageal variceal bleeding: pilot study. Saudi J Gastroenterol (2013) 0.91

Adherence and adequacy of therapy for esophageal varices prophylaxis. Dig Dis Sci (2011) 0.90

A comparative study of the elective treatment of variceal hemorrhage with beta-blockers, transendoscopic sclerotherapy, and surgery: a prospective, controlled, and randomized trial during 10 years. Ann Surg (2000) 0.90

Factors related to early mortality in cirrhotic patients bleeding from varices and treated by urgent sclerotherapy. Gut (1992) 0.89

Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices. Ann Surg (2006) 0.89

Effect of propranolol on portal pressure and systemic hemodynamics in patients with liver cirrhosis and portal hypertension: a prospective study. Gut Liver (2007) 0.89

Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding. Gut (1998) 0.88

Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol (2010) 0.87

Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients. Dig Dis Sci (2005) 0.87

Clinical Management of Chronic Portal/Mesenteric Vein Thrombosis: The Surgeon's Point of View. Viszeralmedizin (2014) 0.86

Clinical outcomes of gastric variceal obliteration using N-butyl-2-cyanoacrylate in patients with acute gastric variceal hemorrhage. Korean J Intern Med (2014) 0.86

Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapies. Hepatology (2013) 0.86

Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis. J Korean Med Sci (2008) 0.86

Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin Gastroenterol Hepatol (2011) 0.85

A comparative pharmacokinetic study of conventional propranolol and long acting preparation of propranolol in patients with cirrhosis and normal controls. Br J Clin Pharmacol (1987) 0.84

Application of endoscopy in improving survival of cirrhotic patients with acute variceal hemorrhage. Int J Hepatol (2011) 0.84

Transjugular intrahepatic portosystemic shunt. Clin Liver Dis (2014) 0.84

Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: a meta-analysis. World J Gastroenterol (2010) 0.83

Doppler surrogate endoscopy for screening esophageal varices in patients with cirrhosis. Hepat Mon (2014) 0.83

Changes in the clinical outcomes of variceal bleeding in cirrhotic patients: a 10-year experience in gangwon province, South Korea. Gut Liver (2012) 0.83

Emergency portacaval shunt for variceal hemorrhage. A prospective study. Ann Surg (1987) 0.83

The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82

Esophageal variceal ligation in the secondary prevention of variceal bleeding: Result of long term follow-up. Pan Afr Med J (2013) 0.81

Improved survival with the patients with variceal bleed. Int J Hepatol (2011) 0.81

MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding. World J Gastroenterol (2011) 0.81

Transjugular portosystemic stent shunt in treatment of liver diseases. World J Gastroenterol (2001) 0.81

Liver transplantation in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis. Transplant Proc (2010) 0.81

Endoscopic management of esophageal varices. World J Gastrointest Endosc (2012) 0.81

Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices? A randomized controlled study. Dig Dis Sci (1997) 0.81

Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding. World J Gastroenterol (2014) 0.80

Octreotide in variceal bleeding. Gut (1994) 0.80

Is portal-systemic shunt worthwhile in Child's class C cirrhosis? Long-term results of emergency shunt in 94 patients with bleeding varices. Ann Surg (1992) 0.80

Adjusted blood requirement index as indicator of failure to control acute variceal bleeding. Croat Med J (2006) 0.79

Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study. Gut (1996) 0.79

Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage. Dig Dis Sci (2013) 0.79

Historical overview and review of current day treatment in the management of acute variceal haemorrhage. World J Gastroenterol (2014) 0.79

Variceal bleeding: does variable delay in trial entry invalidate comparison between trials? Gut (1987) 0.79

Practical approach to endoscopic management for bleeding gastric varices. Korean J Radiol (2012) 0.78

Prevention and management of variceal hemorrhage. Int J Hepatol (2013) 0.78

Gastric varices: Classification, endoscopic and ultrasonographic management. J Res Med Sci (2015) 0.78

Emergency portacaval shunt versus rescue portacaval shunt in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis--part 3. J Gastrointest Surg (2010) 0.78

Clinical results of the transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of variceal bleeding. Korean J Intern Med (2000) 0.78

Liver transplantation in patients with liver cirrhosis and esophageal bleeding. Langenbecks Arch Surg (2003) 0.77

Cyanoacrylate injection compared with band ligation for acute gastric variceal hemorrhage: a meta-analysis of randomized controlled trials and observational studies. Gastroenterol Res Pract (2014) 0.77

Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: a lesson from the past. World J Gastroenterol (2006) 0.77

String capsule endoscopy for screening and surveillance of esophageal varices in patients with cirrhosis. J Interv Gastroenterol (2012) 0.77

Endoscopic injection sclerotherapy in patients with bleeding esophageal varices: a retrospective analysis. Korean J Intern Med (1990) 0.77

Serum type IV collagen level is predictive for esophageal varices in patients with severe alcoholic disease. World J Gastroenterol (2008) 0.77

Upper gastrointestinal bleeding from duodenal vascular ectasia in a patient with cirrhosis. World J Gastroenterol (2007) 0.77

Esophageal varices on computed tomography and subsequent variceal hemorrhage. Abdom Imaging (2014) 0.77

Recent advances in the management of variceal bleeding. Gastroenterol Rep (Oxf) (2017) 0.76

Role of interventional radiology in the emergent management of acute upper gastrointestinal bleeding. Semin Intervent Radiol (2012) 0.76

Variceal sclerotherapy: further progress. Gut (1987) 0.76

Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach. Clin Mol Hepatol (2016) 0.75

A prospective randomized controlled clinical trial comparing the effects of somatostatin and vasopressin for control of acute variceal bleeding in the patients with liver cirrhosis. Korean J Intern Med (2003) 0.75

Proton pump inhibitor administration delays rebleeding after endoscopic gastric variceal obturation. World J Gastroenterol (2014) 0.75

Acute management and secondary prophylaxis of esophageal variceal bleeding: a western Canadian survey. Can J Gastroenterol (2006) 0.75

Changes in Cardiac Varices and Their Clinical Significance after Eradication of Esophageal Varices by Band Ligation. Can J Gastroenterol Hepatol (2016) 0.75

Nonendoscopic management strategies for acute esophagogastric variceal bleeding. Gastroenterol Clin North Am (2014) 0.75

Post-gastrectomy spleen enlargement and esophageal varices: distal vs total gastrectomy. World J Gastroenterol (2010) 0.75

A fourfold increase of oesophageal variceal bleeding in cirrhotic patients with a history of oesophageal variceal bleeding. Singapore Med J (2015) 0.75

Noninvasive predictors of large varices in patients hospitalized with gastroesophageal variceal hemorrhage. Hepatol Int (2007) 0.75

Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension. ISRN Hepatol (2013) 0.75

Management of the Cirrhotic Patient Before Liver Transplantation: The Role of the Referring Gastroenterologist. Gastroenterol Hepatol (N Y) (2006) 0.75

Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension. Oncotarget (2016) 0.75

Mortality with oesophageal varices: different things to different people. Gut (2002) 0.75

Towards noninvasive detection of oesophageal varices. Int J Hepatol (2012) 0.75

Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers. Am J Gastroenterol (2016) 0.75

Targeted long-term venous occlusion using pulsed high-intensity focused ultrasound combined with a pro-inflammatory agent. Ultrasound Med Biol (2011) 0.75

The management of an episode of variceal bleeding. Postgrad Med J (1991) 0.75

Cost saving by reloading the multiband ligator in endoscopic esophageal variceal ligation: a proposal for developing countries. World J Gastroenterol (2008) 0.75

Predictors of In-Hospital Mortality in patients with hepatocellular carcinoma and Acute Variceal bleeding. Electron Physician (2015) 0.75

Portal hypertension. J R Soc Med (1982) 0.75

Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. Ann Gastroenterol (2013) 0.75

Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes. World J Gastroenterol (2016) 0.75

Articles by these authors

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia (2003) 13.41

The mass and oxygen capacity of the blood in man. J Physiol (1900) 10.55

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1995) 9.77

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther (2002) 6.17

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother (1996) 6.01

Norwalk virus genome cloning and characterization. Science (1990) 5.83

Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A (1999) 5.66

Crystal structure of core streptavidin determined from multiwavelength anomalous diffraction of synchrotron radiation. Proc Natl Acad Sci U S A (1989) 5.57

Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02

Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87

The Absorption of Oxygen by the Lungs. J Physiol (1897) 4.50

In vitro transcription and translation of simian rotavirus SA11 gene products. J Virol (1980) 4.40

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA (1999) 4.25

Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol (1999) 4.13

Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology (1998) 4.12

Detection of Norwalk virus in stool by polymerase chain reaction. J Clin Microbiol (1992) 3.82

A prospective study of advance directives for life-sustaining care. N Engl J Med (1991) 3.72

A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology (1989) 3.66

A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A (2000) 3.66

Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol (1996) 3.57

Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol (1997) 3.56

The Oxygen Tension of Arterial Blood. J Physiol (1896) 3.40

oskar mRNA is localized to the posterior pole of the Drosophila oocyte. Cell (1991) 3.39

Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol (1996) 3.32

Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol (1998) 3.31

A protein catalytic framework with an N-terminal nucleophile is capable of self-activation. Nature (1995) 3.30

The pathological effects due to increase of oxygen tension in the air breathed. J Physiol (1899) 3.28

Stages in the nuclear association of the herpes simplex virus transcriptional activator protein ICP4. J Virol (1987) 3.24

Hepatitis B infection in physicians. Results of a nationwide seroepidemiologic survey. JAMA (1978) 3.24

Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol (1996) 3.20

N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun (1988) 3.16

Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet (1991) 3.09

Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol (1993) 2.96

Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res (1984) 2.95

Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology (1992) 2.83

Structure of myohemerythrin in the azidomet state at 1.7/1.3 A resolution. J Mol Biol (1987) 2.79

Identification, synthesis, and modifications of simian rotavirus SA11 polypeptides in infected cells. J Virol (1982) 2.67

A plaque assay for the simian rotavirus SAII. J Gen Virol (1979) 2.65

A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother (1997) 2.63

Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology (1982) 2.60

Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology (1999) 2.54

Rotavirus stability and inactivation. J Gen Virol (1979) 2.48

Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother (1997) 2.47

Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med (1994) 2.47

Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med (1991) 2.46

Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood (2000) 2.45

Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology (1999) 2.44

Patients, payers, and paradigm shifts: what to do about Helicobacter pylori. Am J Gastroenterol (1996) 2.43

Paracentric inversions in humans: a review of 446 paracentric inversions with presentation of 120 new cases. Am J Med Genet (1995) 2.39

Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter (1998) 2.39

Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. Clin Infect Dis (1998) 2.38

Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol (1997) 2.37

Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc (1994) 2.36

Spirochetes in the aqueous humor in seronegative ocular syphilis. Persistence after penicillin therapy. Arch Ophthalmol (1967) 2.30

Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med (1984) 2.29

Motility in Pseudomonas fluorescens with special reference to survival advantage and negative chemotaxis. Life Sci (1968) 2.17


Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol (1994) 2.16

Spontaneous regression of primary malignant melanomas with regional metastases. Cancer (1965) 2.15

Structure of a dehydratase-isomerase from the bacterial pathway for biosynthesis of unsaturated fatty acids: two catalytic activities in one active site. Structure (1996) 2.14

Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut (1994) 2.14

Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13

Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet (1993) 2.12

The crystal structure of GMP synthetase reveals a novel catalytic triad and is a structural paradigm for two enzyme families. Nat Struct Biol (1996) 2.11

Pancreatic-biliary ascariasis: experience of 300 cases. Am J Gastroenterol (1997) 2.10

A new modification of the Krajian silver stain for Treponema pallidum. Br J Vener Dis (1969) 2.09

Mycobacteria and inflammatory bowel disease. Results of culture. Gastroenterology (1987) 2.07

Using the Internet for psychological research: personality testing on the World Wide Web. Br J Psychol (1999) 2.06

Polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp silvaticum in long term cultures from Crohn's disease and control tissues. Gut (1992) 2.06

Nucleic acid hybridization studies of mycobactin-dependent mycobacteria. J Clin Microbiol (1988) 2.06

Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol (1987) 2.05

Direct phase determination based on anomalous scattering. Methods Enzymol (1985) 2.02

Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00

Hereditary aspects of malignant melanoma. JAMA (1967) 1.98

Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect (2000) 1.97

Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol (1988) 1.97

Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun (1995) 1.97

Gastric adaptation. Studies in humans during continuous aspirin administration. Gastroenterology (1988) 1.97

Helicobacter pylori in the drinking water in Peru. Gastroenterology (1996) 1.95

Incidence of reactive VDRL tests in the normal rabbit. Br J Vener Dis (1967) 1.94

Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reaction. J Clin Microbiol (1993) 1.94

Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by in situ hybridization. Am J Gastroenterol (2001) 1.93

Helicobacter pylori infection produces reversible glycosylation changes to gastric mucins. Virchows Arch (1998) 1.91

T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens. Clin Exp Immunol (1976) 1.91

Noninvasive detection of Helicobacter pylori infection in clinical practice: the 13C urea breath test. Am J Gastroenterol (1996) 1.89

Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med (1999) 1.88

Biochemical mapping of the simian rotavirus SA11 genome. J Virol (1983) 1.88


Letter: the ethics of using inferior regimens in H. pylori randomised trials. Aliment Pharmacol Ther (2012) 1.87

B- and T-lymphocyte markers on transformed lymphocytes from mitogen-stimulated cultures of normal and CLL lymphocytes and on tonsil blasts. Clin Exp Immunol (1974) 1.86

Multiple RNA regulatory elements mediate distinct steps in localization of oskar mRNA. Development (1993) 1.86

Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori. J Bacteriol (1993) 1.85

Optic nerve sheath decompression for relief of chronic monocular choked disc. Am J Ophthalmol (1969) 1.84

Microbiology of the frankfurter process: salmonella and natural aerobic flora. Appl Microbiol (1974) 1.83

Muscle fibre type populations of human leg muscles. Histochem J (1975) 1.83

Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics (1991) 1.82

Proteolytic enhancement of rotavirus infectivity: biology mechanism. Virology (1980) 1.81